Y-Intercept »

Lb Pharmaceuticals shares owned by Y-Intercept

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 39k 32.46

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
Trails Edge Capital Partners
Commodore Capital
Jpmorgan Chase & Co
TCG Crossover Management
Caligan Partners
Spruce Street Capital
Nantahala Capital Management
Vanguard Capital Management
Balyasny Asset Management
Alyeska Investment Group
Vivo Capital
Nan Fung Group Holdings

View all funds holding Lb Pharmaceuticals